This page contains exclusive content for the member of the following sections: TTS, TID
Presenter: Camille, Kotton, Boston, United States
Authors:
CMV is the most common infection after solid organ transplantation. Through optimal method of prevention, diagnosis and treatment of CMV, overall outcomes can be significantly enhanced. Guidelines have been developed that encourage best practices, which will be reviewed. In recent years, multiple new agents with activity against CMV have appeared on the horizon, and their role in management of transplant patients will be mentioned. In addition, novel diagnostics may help manage complex patients. Advances in the field, as well as novel concepts and expert opinions, will be covered in this talk.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada